(Press-News.org) UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to those astronauts experience during extravehicular activities (EVAs), or space walks.
The training will enhance the hands-on learning experience of fellows in the Space Medicine Fellowship program, giving them a deeper understanding of physiological and medical challenges encountered in extreme environments.
“Integrating commercial diving insights with advanced medical training provides these fellows with unparalleled expertise in managing extreme conditions,” said Richard Johnston, an instructor at The Ocean Corporation with experience in commercial diving and emergency medicine, as well as an Air Force background.
The collaboration focuses on preparing physicians for the unique health care challenges of space missions. Nicolas Heft, MD, the director of the Space Medicine Fellowship and an alumnus of the program, has developed an innovative curriculum that now includes practical hyperbaric environment training, where fellows will practice managing pressure changes, working under stressful conditions, and planning medical support for extreme environments.
This training is particularly relevant for long-duration space missions.
“The training will allow our fellows to experience firsthand some of the challenges that astronauts experience when performing space walks both in microgravity and on the surface of the moon,” Heft said.
“The UTHealth Houston Space Medicine program builds on decades of aerospace medicine research to develop a completely novel training pathway specifically designed for the future of human space travel,” said Curtis Lowery, MD, PhD, UTHealth Houston’s second-year fellow. “This dive training prepares us for various medical scenarios that can occur on expeditionary missions in space such as EVA support and treatment of barotrauma-related injuries.”
The collaboration between The Ocean Corporation and UTHealth Houston ensures that the next generation of space medicine professionals will receive leading-edge training.
“Collaborating with UTHealth Houston is a leap forward in our commitment to innovating education that meets the challenges of future space exploration,” said John Wood, president of The Ocean Corporation. “We’re equipping medical professionals to enhance human health, both on Earth and in space."
END
The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program
2024-09-19
ELSE PRESS RELEASES FROM THIS DATE:
Mysteries of the bizarre ‘pseudogap’ in quantum physics finally untangled
2024-09-19
By cleverly applying a computational technique, scientists have made a breakthrough in understanding the ‘pseudogap,’ a long-standing puzzle in quantum physics with close ties to superconductivity. The discovery, presented in the September 20 issue of Science, will help scientists in their quest for room-temperature superconductivity, a holy grail of condensed matter physics that would enable lossless power transmission, faster MRI machines and superfast levitating trains.
Certain materials involving copper and oxygen display superconductivity (where electricity flows without resistance) at relatively high — but still frigid — temperatures below ...
Study: Proteins in tooth enamel offer window into human wellness
2024-09-19
A new way of looking at tooth enamel could give scientists a path to deeper understanding of the health of human populations, from the ancient to the modern.
The method, published this week in the Journal of Archaeological Science, examines two immune proteins found embedded in human tooth enamel: immunoglobulin G, an antibody that fights infection, and C-reactive protein, which is present during inflammation in the body.
“These proteins are present in tooth enamel, and they are something we can use to study the ...
New cancer cachexia treatment boosts weight gain and patient activity
2024-09-19
Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia (ku-KEK-see-uh), a common condition related to cancer that involves weight loss and muscle wasting.
The results of the randomized phase 2 clinical trial, which included187 individuals who experienced cachexia with lung, pancreatic, or colorectal cancer, were reported in the New England Journal of Medicine on Sept. 14, 2024. Richard Dunne, MD, MS, a Wilmot Cancer Institute oncologist and cachexia expert was part of the large group of investigators ...
Rensselaer researcher receives $3 million grant to explore gut health
2024-09-19
Blanca Barquera's investigation into the energy-generating processes of Bacteroides, the most abundant member of the gut microbiome, and their impact on our well-being holds the promise of significant advancements in human health. Barquera is a professor at Rensselaer Polytechnic Institute in the Departments of Biological Sciences and Chemistry and Chemical Biology.
In recent years, it has become increasingly clear that an unhealthy gut is more than just a source of digestive troubles. A healthy ...
Elam named as a Fellow of the Electrochemical Society
2024-09-19
Jeffrey Elam, senior chemist, Distinguished Fellow, and founder of the atomic layer deposition (ALD) research program at the U.S. Department of Energy’s Argonne National Laboratory, was named as a fellow of the Electrochemical Society (ECS), which focuses on advancing theory and practice at the forefront of electrochemical and solid-state science and technology. Elam, who has been with the lab since 2002, has been a trailblazer in thin film coating science and technology for over 20 years, ...
Study reveals gaps in access to long-term contraceptive supplies
2024-09-19
Oregon Health & Science University researchers have found that despite legislation in 19 states requiring insurers to cover a 12-month supply of contraception, patients aren’t receiving a year’s worth of their prescription; most receive just three months or less.
Their study recently published in the journal JAMA Health Forum shows that policies requiring coverage of a 12-month supply of short-acting hormonal contraception — most commonly the birth control pill — have not been fully implemented, resulting in no substantial increases nationally in year-long prescription orders. This leaves many patients at an increased risk for unintended ...
Shining a light on the roots of plant “intelligence”
2024-09-19
All living organisms emit a low level of light radiation, but the origin and function of these 'biophotons' are not yet fully understood. An international team of physicists, funded by the Foundational Questions Institute, FQxI, has proposed a new approach for investigating this phenomenon based on statistical analyses of this emission. Their aim is to test whether biophotons can play a role in the transport of information within and between living organisms, and whether monitoring biophotons could contribute to the development of medical techniques for the early diagnosis of various diseases. Their analyses of the measurements of the faint glow emitted by lentil ...
Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections
2024-09-19
Antibiotic-resistant bacterial infections often occur in patients with chronic inflammatory intestinal conditions, such as inflammatory bowel disease, and in patients who have taken antibiotics for a long time. Gram-negative bacteria such as Enterobacteriaceae are a common cause of these infections and have few treatment options. Fecal microbiota transplants have shown promise to curb some of these infections, but their composition varies between batches and they aren’t always successful.
Researchers at Keio University School of Medicine in Tokyo and the Broad Institute of MIT and Harvard have isolated ...
Pushing kidney-stone fragments reduces stones’ recurrence
2024-09-19
Sometimes all it takes is a little push.
That is the conclusion of a recently published study in which doctors used a handheld ultrasound device to nudge patients’ kidney-stone fragments.
As many as 50% of patients who have kidney stones removed surgically still have small fragments remaining in the kidneys afterward. Of those patients, about 25% find themselves returning for another operation within five years to remove the now-larger fragments.
UW Medicine researchers found, however, that patients ...
Sweet success: genomic insights into the wax apple's flavor and fertility
2024-09-19
A recent study has successfully decoded the autotetraploid genome of the wax apple, uncovering its genetic evolution and key factors driving fruit diversity. The research highlights the fruit’s rich antioxidant profile, with promising implications for human health and breeding strategies aimed at enhancing nutritional value.
Wax apple (Syzygium samarangense), known for its crisp texture, rose-like aroma, and health benefits, faces breeding challenges due to its complex genetic diversity and limited genomic data. These obstacles have hindered efforts to improve key fruit qualities such as size and sugar ...